A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN-amplified neuroblastoma

被引:2
|
作者
Zhang, Hai-Feng [1 ,2 ]
Delaidelli, Alberto [1 ,2 ]
Javed, Sumreen [3 ]
Turgu, Busra [1 ,2 ]
Morrison, Taylor [2 ]
Hughes, Christopher S. [1 ,2 ]
Yang, Xiaqiu [2 ]
Pachva, Manideep [1 ,2 ]
Lizardo, Michael M. [1 ,2 ]
Singh, Gurdeep [2 ]
Hoffmann, Jennifer [4 ,5 ]
Huang, Yue Zhou [2 ]
Patel, Khushbu [4 ,5 ,6 ]
Shraim, Rawan [4 ,5 ,7 ]
Kung, Sonia H. Y. [8 ]
Morin, Gregg B. [9 ,10 ]
Aparicio, Samuel [1 ,2 ]
Martinez, Daniel [4 ,5 ,6 ]
Maris, John M. [4 ,5 ,6 ]
Bosse, Kristopher R. [4 ,5 ,6 ]
Williams, Karla C. [3 ]
Sorensen, Poul H. [1 ,2 ]
机构
[1] Univ British Columbia, Dept Pathol & Lab Med, 2211 Wesbrook Mall, Vancouver, BC V6T 1Z4, Canada
[2] BC Canc Agcy, Dept Mol Oncol, Vancouver, BC V5Z 1L3, Canada
[3] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada
[4] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA
[5] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA
[6] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA
[7] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA
[8] Vancouver Prostate Ctr, Vancouver, BC V6H 3Z6, Canada
[9] Canadas Michael Smith Genome Sci Ctr, Vancouver V5Z 4S6, BC, Canada
[10] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T1Z4, Canada
基金
加拿大健康研究院;
关键词
MIGRATION INHIBITORY FACTOR; DEAD BOX GENE; PLEIOTROPIC ROLE; GREB1; MEDULLOBLASTOMA; COAMPLIFICATION; EXPRESSION; MORPHOLOGY; REGULATOR; PROTEINS;
D O I
10.1126/sciadv.adg6693
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
MYCN amplification (MNA) is a defining feature of high-risk neuroblastoma (NB) and predicts poor prognosis. However, whether genes within or in close proximity to the MYCN amplicon also contribute to MNA(+) NB remains poorly understood. Here, we identify that GREB1, a transcription factor encoding gene neighboring the MYCN locus, is frequently coexpressed with MYCN and promotes cell survival in MNA(+) NB. GREB1 controls gene expression independently of MYCN, among which we uncover myosin 1B (MYO1B) as being highly expressed in MNA(+) NB and, using a chick chorioallantoic membrane (CAM) model, as a crucial regulator of invasion and metastasis. Global secretome and proteome profiling further delineates MYO1B in regulating secretome reprogramming in MNA(+) NB cells, and the cytokine MIF as an important pro-invasive and pro-metastatic mediator of MYO1B activity. Together, we have identified a putative GREB1-MYO1B-MIF axis as an unconventional mechanism promoting aggressive behavior in MNA(+) NB and independently of MYCN.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Favorable histology, MYCN-amplified 4S neonatal neuroblastoma
    Chan, Edward L.
    Harris, Richard E.
    Emery, Kathleen H.
    Gelfand, Michael J.
    Collins, Margaret H.
    Gruppo, Ralph A.
    PEDIATRIC BLOOD & CANCER, 2007, 48 (04) : 479 - 482
  • [42] GMDS is a key driver of MYCN-amplified neuroblastoma core fucosylation and tumorigenesis
    Zhu, Beibei
    Pitts, Michelle
    Buoncristiani, Michael
    Bryant, Lindsay
    Lopez-Nunez, Oscar
    Gurria, Juan
    Shedlock, Cameron
    Ribas, Roberto
    Keohane, Shannon
    Liu, Jinpeng
    Wang, Chi
    Gentry, Matt
    Shelman, Nathan
    Allison, Derek
    Evers, B. Mark
    Sun, Ramon
    Rellinger, Eric J.
    CANCER RESEARCH, 2024, 84 (06)
  • [43] The genetic tumor background is an important determinant for heterogeneous MYCN-amplified neuroblastoma
    Bogen, Dominik
    Brunner, Clemens
    Walder, Diana
    Ziegler, Andrea
    Abbasi, Reza
    Ladenstein, Ruth L.
    Noguera, Rosa
    Martinsson, Tommy
    Amann, Gabriele
    Schilling, Freimut H.
    Ussowicz, Marek
    Benesch, Martin
    Ambros, Peter F.
    Ambros, Inge M.
    INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (01) : 153 - 163
  • [44] CD55, a potential immunotherapeutic target for MYCN-amplified neuroblastoma
    Yoda, Hiroyuki
    Weiss, William A.
    NEURO-ONCOLOGY, 2022, 24 (06) : 886 - 887
  • [45] Transcriptional Repression of SKP2 Is Impaired in MYCN-Amplified Neuroblastoma
    Muth, Daniel
    Ghazaryan, Seda
    Eckerle, Isabella
    Beckett, Emily
    Poehler, Christina
    Batzler, Julia
    Beisel, Claudia
    Gogolin, Sina
    Fischer, Matthias
    Henrich, Kai-Oliver
    Ehemann, Volker
    Gillespie, Paul
    Schwab, Manfred
    Westermann, Frank
    CANCER RESEARCH, 2010, 70 (09) : 3791 - 3802
  • [46] Inhibition of the ALDH18A1-MYCN positive feedback loop attenuates MYCN-amplified neuroblastoma growth
    Guo, Yu-Feng
    Duan, Jiang-Jie
    Wang, Jun
    Li, Lin
    Wang, Di
    Liu, Xun-Zhou
    Yang, Jing
    Zhang, Hua-Rong
    Lv, Jing
    Yang, Yong-Jun
    Yang, Ze-Yu
    Cai, Jiao
    Liao, Xue-Mei
    Tang, Tao
    Huang, Ting-Ting
    Wu, Feng
    Yang, Xian-Yan
    Wen, Qian
    Bian, Xiu-Wu
    Yu, Shi-Cang
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (531)
  • [47] A Novel MYCN-Specific Antigene Oligonucleotide Deregulates Mitochondria and Inhibits Tumor Growth in MYCN-Amplified Neuroblastoma
    Montemurro, Luca
    Raieli, Salvatore
    Angelucci, Silvia
    Bartolucci, Damiano
    Amadesi, Camilla
    Lampis, Silvia
    Scardovi, Anna Lisa
    Venturelli, Leonardo
    Nieddu, Giammario
    Cerisoli, Lucia
    Fischer, Matthias
    Teti, Gabriella
    Falconi, Mirella
    Pession, Andrea
    Hrelia, Patrizia
    Tonelli, Roberto
    CANCER RESEARCH, 2019, 79 (24) : 6166 - 6177
  • [48] MYCN and Metabolic Reprogramming in Neuroblastoma
    Bansal, Mohit
    Gupta, Anamika
    Ding, Han-Fei
    CANCERS, 2022, 14 (17)
  • [49] Vasoactive intestinal peptide decreases MYCN expression and synergizes with retinoic acid in a human MYCN-amplified neuroblastoma cell line
    Chevrier, Lucie
    Meunier, Annie-Claire
    Cochaud, Stephanie
    Muller, Jean-Marc
    Chadeneau, Corinne
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2008, 33 (05) : 1081 - 1089
  • [50] Aurora-A stabilizes N-myc protein in MYCN-amplified neuroblastoma
    Berwanger, B.
    Otto, T.
    Horn, S.
    Schuettstrumpf, L.
    Kenney, A.
    Eilers, U.
    Eggert, A.
    Christiansen, H.
    Eilers, M.
    KLINISCHE PADIATRIE, 2008, 220 (03): : 198 - 198